These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Multimodal Imaging of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer-A State-of-the-Art Review. Cronin M; Seher M; Arsang-Jang S; Lowery A; Kerin M; Wijns W; Soliman O J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834939 [TBL] [Abstract][Full Text] [Related]
84. Quantitative cardiovascular magnetic resonance findings and clinical risk factors predict cardiovascular outcomes in breast cancer patients. Kwan JM; Arbune A; Henry ML; Hu R; Wei W; Nguyen V; Lee S; Lopez-Mattei J; Guha A; Huber S; Bader AS; Meadows J; Sinusas A; Mojibian H; Peters D; Lustberg M; Hull S; Baldassarre LA PLoS One; 2023; 18(5):e0286364. PubMed ID: 37252927 [TBL] [Abstract][Full Text] [Related]
85. A Patent Review on Cardiotoxicity of Anticancerous Drugs. Bhadana R; Rani V Cardiovasc Hematol Agents Med Chem; 2023; 22(1):28-39. PubMed ID: 36683367 [TBL] [Abstract][Full Text] [Related]
86. Detection of Cardiac Toxicity Due to Cancer Treatment: Role of Cardiac MRI. Meyersohn NM; Pursnani A; Neilan TG Curr Treat Options Cardiovasc Med; 2015 Aug; 17(8):396. PubMed ID: 26134969 [TBL] [Abstract][Full Text] [Related]
87. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity. O'Hare M; Murphy K; Mookadam F; Sharma A; Lee H Expert Rev Cardiovasc Ther; 2015 May; 13(5):519-27. PubMed ID: 25864865 [TBL] [Abstract][Full Text] [Related]
88. Are cardiac magnetic resonance imaging and radionuclide ventriculography good options against echocardiography for evaluation of anthracycline induced chronic cardiotoxicity in childhood cancer survivors? Basar EZ; Corapcioglu F; Babaoglu K; Anik Y; Gorur Daglioz G; Dedeoglu R Pediatr Hematol Oncol; 2014 Apr; 31(3):237-52. PubMed ID: 24499452 [TBL] [Abstract][Full Text] [Related]
89. A Systematic Review of the Cardiotoxic Effects of Targeted Therapies in Oncology. Hauwanga WN; McBenedict B; Amadi ES; Dohadwala TK; Johnny C; Asaju F; Okafor OD; Jimoh A; Elumah AAO; Onyinyinyechi OV; Petrus D; Lima Pessôa B Cureus; 2024 Aug; 16(8):e66258. PubMed ID: 39238728 [TBL] [Abstract][Full Text] [Related]
90. Off-Target Effects of Cancer Therapy on Development of Therapy-Induced Arrhythmia: A Review. Leiva O; Bohart I; Ahuja T; Park D Cardiology; 2023; 148(4):324-334. PubMed ID: 36702116 [TBL] [Abstract][Full Text] [Related]
91. Cardiac MRI Features and Prognostic Value in Immune Checkpoint Inhibitor-induced Myocarditis. Cadour F; Cautela J; Rapacchi S; Varoquaux A; Habert P; Arnaud F; Jacquier A; Meilhac A; Paganelli F; Lalevée N; Scemama U; Thuny F Radiology; 2022 Jun; 303(3):512-521. PubMed ID: 35230185 [TBL] [Abstract][Full Text] [Related]
92. Cardiotoxicity of Cancer Treatments: Focus on Anthracycline Cardiomyopathy. Nishi M; Wang PY; Hwang PM Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2648-2660. PubMed ID: 34587760 [TBL] [Abstract][Full Text] [Related]
93. Exercise as Medicine Could Be a Chance for Early Detection and Prevention of Cardiotoxicity in Cancer Treatments: A Narrative Review. Zoth N; Tomanek A; Seuthe K; Pfister R; Baumann FT Oncol Res Treat; 2023; 46(4):131-139. PubMed ID: 36652921 [TBL] [Abstract][Full Text] [Related]
94. Anthracycline-Induced Cardiomyopathy in Adults. Tan TC; Neilan TG; Francis S; Plana JC; Scherrer-Crosbie M Compr Physiol; 2015 Jul; 5(3):1517-40. PubMed ID: 26140726 [TBL] [Abstract][Full Text] [Related]
95. Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology. Yeh ETH; Ewer MS; Moslehi J; Dlugosz-Danecka M; Banchs J; Chang HM; Minotti G Semin Oncol; 2019 Dec; 46(6):397-402. PubMed ID: 31753424 [TBL] [Abstract][Full Text] [Related]
96. Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring. Mikail N; Chequer R; Imperiale A; Meisel A; Bengs S; Portmann A; Gimelli A; Buechel RR; Gebhard C; Rossi A Eur Heart J Cardiovasc Imaging; 2023 Aug; 24(9):1129-1145. PubMed ID: 37467476 [TBL] [Abstract][Full Text] [Related]
97. Assessing for Cardiotoxicity from Metal-on-Metal Hip Implants with Advanced Multimodality Imaging Techniques. Berber R; Abdel-Gadir A; Rosmini S; Captur G; Nordin S; Culotta V; Palla L; Kellman P; Lloyd GW; Skinner JA; Moon JC; Manisty C; Hart AJ J Bone Joint Surg Am; 2017 Nov; 99(21):1827-1835. PubMed ID: 29088037 [TBL] [Abstract][Full Text] [Related]
98. Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients from Southern Sri Lanka: An Echocardiographic Analysis. Sandamali JAN; Hewawasam RP; Fernando MACSS; Jayatilaka KAPW; Madurawe RD; Sathananthan PP; Ekanayake U; Horadugoda J Biomed Res Int; 2020; 2020():1847159. PubMed ID: 33274195 [TBL] [Abstract][Full Text] [Related]
99. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy. Cadour F; Quemeneur M; Biere L; Donal E; Bentatou Z; Eicher JC; Roubille F; Lalande A; Giorgi R; Rapacchi S; Cortaredona S; Tradi F; Bartoli A; Willoteaux S; Delahaye F; Biene SM; Mangin L; Ferrier N; Dacher JN; Bauer F; Leurent G; Lentz PA; Kovacsik H; Croisille P; Thuny F; Bernard M; Guye M; Furber A; Habib G; Jacquier A J Cardiovasc Magn Reson; 2023 Feb; 25(1):7. PubMed ID: 36747201 [TBL] [Abstract][Full Text] [Related]
100. Application of Photoactive Compounds in Cancer Theranostics: Review on Recent Trends from Photoactive Chemistry to Artificial Intelligence. Szymaszek P; Tyszka-Czochara M; Ortyl J Molecules; 2024 Jul; 29(13):. PubMed ID: 38999115 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]